Skip to main content
. 2022 Feb 4;9(3):ofac043. doi: 10.1093/ofid/ofac043

Figure 1.

Figure 1.

Community-acquired pneumonia treatment algorithms based on coronavirus disease 2019 test results. ∗If Streptococcus pneumoniae susceptibility to macrolides is >75% macrolide. ∗∗If risks for methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa, add appropriate coverage to standard. †Treatment will depend on severity and risk factors for MRSA or P aeruginosa. Abbreviations: CAP, community-acquired pneumonia; COVID-19, coronavirus disease 2019; FQ, fluoroquinolone; MDRO, multidrug-resistant organism; O2, oxygen.